| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of Atrial Fibrillation Reduction in REDUCE LAP-HF II ∗
|
Hahn, Rebecca T.
|
|
|
11 |
10 |
p. 1363-1364
|
artikel
|
| 2 |
Are There Any “Tips” for Better Joint Risk Factor Control in Patients With Diabetes?
|
Sawami, Kosuke
|
|
|
11 |
10 |
p. 1470
|
artikel
|
| 3 |
As We Embark on a Second Year
|
Bozkurt, Biykem
|
|
|
11 |
10 |
p. 1466-1469
|
artikel
|
| 4 |
Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction
|
Patel, Ravi B.
|
|
|
11 |
10 |
p. 1351-1362
|
artikel
|
| 5 |
Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock
|
Berg-Hansen, Kristoffer
|
|
|
11 |
10 |
p. 1337-1347
|
artikel
|
| 6 |
Blood Volume Analysis-Guided Heart Failure Management
|
Fudim, Marat
|
|
|
11 |
10 |
p. 1460-1462
|
artikel
|
| 7 |
Broad Quality of Life Effects for Specific Medications
|
Sears, Samuel F.
|
|
|
11 |
10 |
p. 1424-1426
|
artikel
|
| 8 |
Clinical Course of Patients in Cardiogenic Shock Stratified by Phenotype
|
Zweck, Elric
|
|
|
11 |
10 |
p. 1304-1315
|
artikel
|
| 9 |
Comprehensive Investigation of Latent Pulmonary Vascular Disease
|
Oakland, Hannah T.
|
|
|
11 |
10 |
p. 1439-1442
|
artikel
|
| 10 |
Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction
|
Butt, Jawad H.
|
|
|
11 |
10 |
p. 1411-1423
|
artikel
|
| 11 |
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status
|
Peikert, Alexander
|
|
|
11 |
10 |
p. 1380-1393
|
artikel
|
| 12 |
Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure
|
Martens, Pieter
|
|
|
11 |
10 |
p. 1365-1376
|
artikel
|
| 13 |
Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices
|
Martens, Pieter
|
|
|
11 |
10 |
p. 1289-1303
|
artikel
|
| 14 |
Emerging Opportunities to Reduce Racial, Ethnic, and Gender Disparities in Advanced Heart Failure Care ∗
|
Cascino, Thomas M.
|
|
|
11 |
10 |
p. 1408-1410
|
artikel
|
| 15 |
Full Issue PDF
|
|
|
|
11 |
10 |
p. e1-e183
|
artikel
|
| 16 |
Guideline-Recommended Therapy Following Hospitalization for Heart Failure
|
Averbuch, Tauben
|
|
|
11 |
10 |
p. 1333-1336
|
artikel
|
| 17 |
Hospital at Home as a Novel Care Strategy for Worsening Heart Failure
|
Haywood, Hubert B.
|
|
|
11 |
10 |
p. 1443-1448
|
artikel
|
| 18 |
Jump Starting the Heart
|
Lopaschuk, Gary D.
|
|
|
11 |
10 |
p. 1348-1350
|
artikel
|
| 19 |
Long-Term Effects of Sotatercept on Right Ventricular Function
|
Gomberg-Maitland, Mardi
|
|
|
11 |
10 |
p. 1457-1459
|
artikel
|
| 20 |
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization
|
Bozkurt, Biykem
|
|
|
11 |
10 |
p. 1320-1332
|
artikel
|
| 21 |
Noncardiac Comorbidities in Chronic Heart Failure
|
Mentz, Robert J.
|
|
|
11 |
10 |
p. 1377-1379
|
artikel
|
| 22 |
Opportunities for Change in Home Health Care in Heart Failure ∗
|
Verma, Aradhana
|
|
|
11 |
10 |
p. 1449-1453
|
artikel
|
| 23 |
Perirenal Adipose Tissue Is Associated With Renal Dysfunction and Abnormal Hemodynamics in Patients With HFpEF
|
Boorsma, Eva M.
|
|
|
11 |
10 |
p. 1463-1465
|
artikel
|
| 24 |
Precision Medicine in Cardiogenic Shock
|
Mebazaa, Alexandre
|
|
|
11 |
10 |
p. 1316-1319
|
artikel
|
| 25 |
Prevalence, Incidence, Lifetime Risks, and Outcomes of Heart Failure in Asia
|
Hung, Chung-Lieh
|
|
|
11 |
10 |
p. 1454-1456
|
artikel
|
| 26 |
Racial and Ethnic Disparities in Ambulatory Heart Failure Ventricular Assist Device Implantation and Survival
|
Dixon, Debra D.
|
|
|
11 |
10 |
p. 1397-1407
|
artikel
|
| 27 |
Reply
|
Qi, Lu
|
|
|
11 |
10 |
p. 1471
|
artikel
|
| 28 |
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction
|
Caravita, Sergio
|
|
|
11 |
10 |
p. 1427-1438
|
artikel
|
| 29 |
Topping Off the Pill Box
|
Park, Jin Joo
|
|
|
11 |
10 |
p. 1394-1396
|
artikel
|
Tijdschrift beschrijving